|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-2-20
|
|
pubmed:abstractText |
Alterations of sperm number and motility are found in hyperprolactinaemic men. Cabergoline treatment reverses alterations in semen. No information is currently available on the quality of seminal tests in hyperprolactinemia in response to cabergoline treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
307-13
|
|
pubmed:meshHeading |
pubmed-meshheading:16487441-Adult,
pubmed-meshheading:16487441-Antineoplastic Agents,
pubmed-meshheading:16487441-Case-Control Studies,
pubmed-meshheading:16487441-Drug Administration Schedule,
pubmed-meshheading:16487441-Ergolines,
pubmed-meshheading:16487441-Gonadotropins,
pubmed-meshheading:16487441-Humans,
pubmed-meshheading:16487441-Hyperprolactinemia,
pubmed-meshheading:16487441-Male,
pubmed-meshheading:16487441-Pituitary Neoplasms,
pubmed-meshheading:16487441-Prolactin,
pubmed-meshheading:16487441-Prolactinoma,
pubmed-meshheading:16487441-Prospective Studies,
pubmed-meshheading:16487441-Semen,
pubmed-meshheading:16487441-Sperm Count,
pubmed-meshheading:16487441-Spermatozoa,
pubmed-meshheading:16487441-Testosterone,
pubmed-meshheading:16487441-Time Factors,
pubmed-meshheading:16487441-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males.
|
|
pubmed:affiliation |
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, Italy.
|
|
pubmed:publicationType |
Journal Article
|
